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Background: Administrative and survey data are two key data sources for population-based research about
chronic disease. The objectives of this methodological paper are to: (1) estimate agreement between the two data
sources for irritable bowel syndrome (IBS) and compare the results to those for inflammatory bowel disease (IBD);
(2) compare the frequency of IBS-related diagnoses in administrative data for survey respondents with and without
self-reported IBS, and (3) estimate IBS prevalence from both sources.
Methods: This retrospective cohort study used linked administrative and health survey data for 5,134 adults from
the province of Manitoba, Canada. Diagnoses in hospital and physician administrative data were investigated for
respondents with self-reported IBS, IBD, and no bowel disorder. Agreement between survey and administrative
data was estimated using the  statistic. The c
2 statistic tested the association between the frequency of IBS-
related diagnoses and self-reported IBS. Crude, sex-specific, and age-specific IBS prevalence estimates were
calculated from both sources.
Results: Overall, 3.0% of the cohort had self-reported IBS, 0.8% had self-reported IBD, and 95.3% reported no
bowel disorder. Agreement was poor to fair for IBS and substantially higher for IBD. The most frequent IBS-related
diagnoses among the cohort were anxiety disorders (34.4%), symptoms of the abdomen and pelvis (26.9%), and
diverticulitis of the intestine (10.6%). Crude IBS prevalence estimates from both sources were lower than those
reported previously.
Conclusions: Poor agreement between administrative and survey data for IBS may account for differences in the
results of health services and outcomes research using these sources. Further research is needed to identify the
optimal method(s) to ascertain IBS cases in both data sources.
Background
Both administrative and survey data are used to conduct
population-based health services and outcomes research
about chronic conditions such as diabetes, hypertension,
arthritis, and osteoporosis [1-5]. A primary concern
when using administrative data for studies of chronic
conditions is the accuracy and completeness of diagnos-
tic information [6,7], while recall bias is a key concern
for self-report data. These limitations of both data
sources may result in discrepant research findings, yet
only a few studies have compared administrative and
survey data for ascertaining disease cases.
Okura et al. [8] observed good agreement between
survey and administrative data for ascertaining cases of
diabetes, hypertension, myocardial infarction, and stroke.
Estimates of agreement were substantially lower for
heart failure. Rector et al. [9] found that the sensitivity
of administrative data, when compared to survey data,
was very good for identifying cases of hypertension and
diabetes, but lower for arthritis and heart failure. Other
studies have found moderate to good agreement
between administrative and survey data [4,10-12]. While
agreement tends to be highest for well-defined chronic
conditions, such as diabetes, it also depends on the
case-ascertainment methodology applied to administra-
tive data [11,12]. For example, Rector et al. [9] found
that the number of years of data used to identify chronic
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sensitivity of administrative data.
Recently, administrative data have been investigated as
a potential data source for health services and outcomes
research about irritable bowel syndrome (IBS) [13].
Population-based investigations about IBS have primar-
ily been conducted using survey data [14-16]. IBS is a
common non-inflammatory gastrointestinal condition;
the prevalence in North America is estimated to be
between 7% and 15% [15-17]. Individuals with IBS have
higher health care use and costs than their non-IBS
counterparts [18,19]. IBS is a difficult condition to
investigate in population-based research because there is
no single diagnostic test to confirm disease presence
and the symptoms of IBS may also be associated with
other conditions, including infections. However, when
compared with clinical data or medical charts, diagnoses
in administrative data have shown good specificity for
ascertaining IBS cases [20,21].
This study compares administrative and survey data
for ascertaining cases of IBS. The objectives are to: (1)
estimate agreement between the two data sources for
IBS and compare the results to those for inflammatory
bowel disease (IBD), a gastrointestinal condition with
well-defined diagnostic criteria in comparison with IBS;
(2) compare the frequency of IBS-related diagnoses in
administrative data for survey respondents with and
without self-reported IBS, and (3) estimate IBS preva-
lence from both sources.
Methods
A retrospective cohort study was undertaken using
administrative and survey data from the province of
Manitoba, Canada, which has a population of approxi-
mately 1.2 million. The Research Data Repository
housed at Manitoba Centre for Health Policy (MCHP)
contains administrative data provided by the provincial
health ministry. The Repository also houses population-
based survey data from a national health survey, the
Canadian Community Health Survey (CCHS; http://
www.statcan.gc.ca/concepts/health-sante/cycle3_1/index-
eng.htm) and the two sources can be directly linked via
a unique, anonymized personal health identification
number (PHIN). The University of Manitoba Health
Research Ethics Board approved the conduct of this
research and the Manitoba Health Information Privacy
Committee approved the data linkage.
The survey data were collected between January and
December 2005. The CCHS was developed to provide
cross-sectional estimates of health status, health deter-
minants, and health system use for a target population
of individuals 12 years of age and older living in private
dwellings. The survey does not include individuals living
on Indian Reserves and other government-owned land,
institutional residents, and full-time members of the
Canadian Forces; these groups represent approximately
2% of the Manitoba population. The Manitoba response
rate was 83.3%; the national response rate was 78.9%.
Sources of administrative data were records of inpati-
ent hospitalizations and outpatient physician billing
claims. Manitoba, like other Canadian provinces, has a
universal health system; almost all Manitoba residents
are covered under the Manitoba Health Services Insur-
ance Plan (MHSIP). A hospitalization record is com-
pleted upon patient discharge. Each record includes up
to 16 diagnosis codes from the International Classifica-
tion of Diseases, 9
th Revision, Clinical Modification (i.e.,
ICD-9-CM) prior to April 1, 2004 and up to 25 diagno-
sis codes from the 10th Revision for this date onward (i.
e., ICD-10-CA). Procedure codes are also captured in
hospitalization records. Physicians paid on a fee-for-ser-
vice basis submit billing claims to the provincial health
ministry; these claims capture virtually all outpatient
services, including those for hospital emergency depart-
ments and outpatient departments. While some physi-
cians are salaried (e.g., approximately 7% of family
physicians) [22], it has been estimated that approxi-
mately 90% of these physicians submit parallel billing
claims for administrative purposes. Each visit results in
one billing claim that contains a single ICD-9-CM code.
ICD-9 codes in physician data are recorded to the third
digit, while codes in hospital data are recorded using up
to five digits.
Study Cohort
There were 7,004 Manitoba respondents to the CCHS in
2005. The anonymized linkage of survey and administra-
tive data was conducted for those respondents who pro-
vided their consent for the linkage (N = 6,349; 90.6%).
After removing invalid or missing PHINs, linkage was
successfully achieved for 6,232 respondents (89.0%).
From this sample, an adult cohort (19+ years) with at
least three years of continuous coverage under the
MHSIP prior to the date of their CCHS interview and at
least one year of coverage after this date was created (N
= 5,134; 73.3%). Coverage information was determined
from the population registration file.
The survey interview schedule included the following
directions: “Now I’d like to ask about certain chronic
health conditions which you may have. We are interested
in ‘long-term conditions’ that have lasted or are expected
to last six months or more and that have been diagnosed
b yah e a l t hp r o f e s s i o n a l “. Respondents were asked
whether they had ever been diagnosed with a number of
chronic conditions, including a bowel disorder, specifi-
cally: “Do you suffer from a bowel disorder such as
Crohn’s disease, ulcerative colitis, irritable bowel syn-
drome, or bowel incontinence?“ If the response was affir-
mative, respondents were asked to identify the type of
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Crohn’s disease, ulcerative colitis, irritable bowel syn-
drome, bowel incontinence, or other bowel disorder
(type was not specified). A single category was recorded
for each respondent.
Selection of Diagnosis Codes in Administrative Data
Table 1 provides a listing of the diagnosis and proce-
dures codes in administrative data that were selected for
this investigation [13,20,21]. Previous studies that have
used administrative data to ascertain IBS cases have
only been conducted using ICD-9 codes. In this study it
was also necessary to identify the relevant codes in ICD-
10-CA. This was accomplished using crosswalk files,
which map ICD-9 codes to ICD-10-CA codes, developed
by a national health information agency, the Canadian
Institute of Health Information, and confirmed by
research team members.
The ICD-9-CM diagnosis code for IBS is 564.1; the
corresponding code in ICD-10-CA is K58. Other diag-
nosis and procedure codes that are more common
among individuals with IBS than among individuals
without this condition were identified from previous
research [13,20,21]. These diagnosis codes were for a
variety of gastrointestinal and genitourinary conditions
and symptoms, procedures used to assess the presence
of gastrointestinal inflammation, and some comorbid
conditions. Diagnosis codes for IBD, specifically for
Crohn’s disease (CD) and ulcerative colitis (UC) were
included because some individuals with IBD may have
previously been diagnosed with IBS [23]. Diagnosis and
procedure codes were investigated in administrative data
up to three years prior to the date of the CCHS inter-
view and one year following this date. These time
frames were selected based on previous research which
has used between one and three years of administrative
data to ascertain chronic diseases [12,24].
Crude IBS prevalence estimates, as well as sex- and
age-specific estimates, were generated from administra-
tive and survey data. In the administrative data, two
case-ascertainment algorithms were investigated. For the
first, Manitoba health insurance registrants were identi-
fied as IBS cases if they had a least one IBS diagnosis in
hospital or physician data in a one-year period. For the
second method, registrants were identified as IBS cases
if they had at least one IBS diagnosis in a three-year
period. One-year estimates were based on data for the
2004/05 fiscal year and three-year estimates were based
on data from fiscal years 2002/03 to 2004/05. The popu-
lation registration file was used to obtain the denomina-
tor for these estimates.
Statistical Analysis
Descriptive statistics, including frequencies and percen-
tages, were used to characterize the cohort on demo-
graphic and socioeconomic variables. The  statistic, a
chance-corrected measure of agreement, was estimated
from the administrative and survey data for both IBS
and IBD and 95% confidence intervals (CIs) were com-
puted. The interpretation of  used is [25]: poor agree-
ment ( <0 . 2 0 ) ,f a i ra g r e e m e n t(  =0 . 2 0t o0 . 3 9 ) ,
moderate agreement ( = 0.40 to 0.59), good agreement
( = 0.60 to 0.79), and very good agreement ( =0 . 8 0
to 1.00). The c
2 test was used to test the association
between the frequency of IBS-related diagnoses and pro-
cedures in administrative data and self-reported IBS.
Ninety-five percent CIs were calculated for the preva-
lence estimates assuming a binomial distribution. Survey
sampling weights were used in all inferential analyses;
these weights ensure that the results are generalizable to
the Manitoba population. Analyses were performed
using SAS software [26].
Results
Overall, 152 (3.0%) members of the study cohort
reported having IBS, another 0.8% reported having CD
or UC, and 95.3% reported having no bowel disorder.
Another 49 respondents, who indicated they had bowel
incontinence or another, unspecified bowel disorder,
were excluded from the analysis.
The socio-demographic characteristics of the three
groups are described in Table 2. Males comprised less
than 15.0% of respondents with self-reported IBS, more
than one third of respondents with self-reported CD or
UC, and almost half of respondents with no bowel dis-
order. Almost half of respondents with self-reported IBS
were less than 45 years of age compared to slightly
more than one-third of those who reported no bowel
disorder. The majority of respondents were urban resi-
d e n t s .R e s p o n d e n t sw e r el e s sl i k e l yt ob ei nt h eh i g h e s t
a n dl o w e s ti n c o m eq u i n t i l e sa n dm o r el i k e l yt ob ei n
one of the three middle income categories.
Estimates of agreement between survey and adminis-
trative data are reported in Table 3. Applying the inter-
pretative criteria to these estimates [25], agreement was
poor for IBS when one year of post-interview data was
used for case ascertainment but was fair when three
years of pre-interview data were used. For IBD, agree-
ment was moderate when a single year of post-interview
data was used, but was good when up to three years of
administrative data prior to the interview date were
used.
Table 4 reports the percentage of survey respondents
with self-reported IBS and no self-reported bowel disor-
der for the selected diagnoses and procedures in admin-
istrative data before and after the survey interview date.
None of the survey respondents had an IBS or IBS-
related diagnosis code recorded in hospitalization
records. An IBD diagnosis in hospitalization records was
also rare among self-reported IBS cases. There was a
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doscopy, colonoscopy, or endoscopy procedure in both
three-year and one-year periods before the survey inter-
view and presence of self-reported IBS (p <0 . 0 0 1 ) .
Overall, 11.2% of survey respondents who reported a
diagnosis of IBS had one of the selected procedure
codes in the three years prior to the interview date. In
physician billing claims, 9.4% of the self-reported IBS
cases had an IBS diagnosis prior to the interview date
and a similar percentage (10.7%) had a diagnosis in the
one-year period following this date. An IBS diagnosis
code was present in the physician claims of less than
2.0% of respondents who reported that they did not
have a bowel disorder.
Almost one-quarter of IBS cases had a diagnosis of
IBD in physician claims data up to three years before
the survey interview date, but in the year immediately
before or after the interview date the number of cases
with this diagnosis was too small to analyze. Among IBS
cases, the most frequent IBS-related diagnoses recorded
in physician billing claims in the three-year period
before the survey interview date were anxiety disorders
(34.4%), symptoms involving the abdomen and pelvis
(26.9%), and diverticulitis of the intestine (10.6%). In the
Table 1 Diagnosis and procedure codes selected for the study
Description ICD-9-CM Diagnosis & Procedure
Codes
ICD-10-CA Diagnosis & Procedure Codes
Irritable bowel syndrome 564.1 K58
Other bowel disorders
Crohn’s disease 555 K50
Ulcerative colitis 556 K51
IBS-related diagnoses
Gastric ulcer 531 K25
Duodenal ulcer 532 K26
Peptic ulcer 533 K27
Gastrojejunal ulcer 534 K28
Gastritis and duodenitis 535 K29
Disorders of functions of the stomach 536 K30, K31.0, K31.8, K31.9, R11
Other disorders of stomach and duodenum 537 K31.1 - K31.7
Appendicitis 540, 543 K35, K38.0, K38.8
Vascular insufficiency of intestine 557 K55
Intestinal obstruction 560 K56
Diverticula of intestine 562 K57
Necrosis of liver 570 K72
Chronic liver disease 571 K70, K73.9, K73.8, K74.5, K76.0, K76.9
Liver abscess & sequelae 572 K75.0, K75.1, K72.9, K76.6, K76.7, K76.8
Other disorders of liver 573 K76.1, K77.0, K75.9, K76.3, K76.8, K76.9
Cholelithiasis 574 K80
Other disorders of gallbladder 575 K81.0, K81.8, K82
Other disorders of biliary tract 576 K91.5, K83
Diseases of pancreas 577 K85, K86.1, K86.2, K86.8, K86.9
Intestinal malabsorption 579 K90, K91.2
Symptoms: digestive system 787 R11, R12, R13, R14, R15
Symptoms: urinary system 788 N23, N39.4, R30, R32, R33, R34, R35, R36, R39
Symptoms: abdomen and pelvis 789 R10, R16, R18, R19
Endometriosis 617 N80
Pain and other symptoms: female genital
organs
625 N94
Anxiety disorders 300 F34.1, F40.1, F40.2, F41.0, F41.1, F41.8, F41.9, F42.8, F44.8,
F44.9, F45.2
Intestinal infections: other organisms 008 A04, A08, A02
Ill-defined intestinal infections 009 A09
IBS-related procedures
Sigmoidoscopy, colonoscopy, endoscopy 45.21, 45.22, 45.23, 45.24, 45.28, 48.23 2.NM.70, 2.OW.70
Small bowel series 87.63 3.NK.10
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common IBS-related diagnoses were anxiety disorders
(20.7%), symptoms involving the abdomen and pelvis
(10.2%), and symptoms involving the urinary system
(4.2%). These were also the most common IBS-related
diagnoses among non-cases, but the percentages were
significantly different (p < 0.001 for all tests) for the two
groups.
The crude IBS prevalence estimate from survey data
was 3.00 per 100 (95% CI: 2.37, 3.76). Using administra-
tive data, the crude prevalence estimate was 1.71 per
100 (95% CI: 1.69, 1.74) for a one-year case-ascertain-
ment algorithm and 4.23 per 100 (95% CI: 4.19, 4.28)
for a three-year algorithm. The number of IBS cases
identified from hospitalization data was small; for the
former algorithm, 1.74% of cases were identified solely
from hospital data and for the latter algorithm the cor-
responding figure was 0.43% of cases.
Both administrative and survey data resulted in higher
prevalence estimates for females than for males (Figure
1); the ratio was 4.27 for survey data, 2.14 for the one-
year algorithm and 2.08 for the three-year algorithm.
The analysis by age group (Figure 2) revealed that for
the two youngest age groups, prevalence estimates from
administrative and survey data were not significantly dif-
ferent (p ≤ .10 for both administrative data algorithms).
For the oldest age group, they were significantly higher
using administrative data than survey data.
Discussion
This study compared population-based administrative
and survey data for IBS diagnoses. The results show
that agreement between administrative and survey data
for IBS was low, but it was much higher for IBD.
Agreement was investigated for two periods of time
both before and after the survey interview date. Agree-
ment between administrative and survey data remained
low regardless of the size or direction (i.e., pre-interview
versus post-interview) of the case-ascertainment
window.
Compared with survey respondents who reported hav-
ing no bowel disorder, respondents with a self-reported
diagnosis of IBS were more likely to have diagnoses in
administrative data for symptoms of the digestive system
and abdomen, other gastrointestinal conditions includ-
ing IBD, selected procedures, and an anxiety disorder.
These findings are consistent with previous research,
which has shown that that IBS patients have an
increased likelihood of diagnosis for a variety of gastro-
intestinal, genitourinary, and psychological conditions
when compared with the general population [21,27].
Given that IBD and IBS may have similar symptoms, an
increased frequency of diagnosis for IBD may be indica-
tive of physicians attempting to “rule out” the presence
of this condition in IBS patients [23]. A recent Canadian
study [28] found that physicians are accurate in their
use of ICD-9 diagnosis codes for Crohn’s disease and
ulcerative colitis in billing claims. Thus, the increased
frequency of IBD diagnosis among IBS patients does not
appear to be due to inaccuracies in diagnoses.
Table 2 Characteristics of study cohort
Characteristic Self-Reported IBS (n =
152)
Self-Reported CD or UC (n =
41)
No Reported Bowel Disorder (n =
4,892)
n% n % n %
Sex Male 22 14.4 15 36.5 2,258 46.2
Female 130 85.6 26 63.5 2,634 53.8
Age Group < 45 years 68 44.7 18 43.9 1,916 39.2
45 - 64 years 63 41.5 14 34.1 1,693 34.6
65+ years 21 13.8 9 22.0 1,283 26.4
Region of Residence Urban 105 69.1 29 70.7 3,156 64.5
Rural 47 30.9 12 29.3 1,736 35.5
Income Quintile
a Q1 (lowest) 20 13.2 –– 809 16.5
Q2 35 23.0 –– 1014 20.7
Q3 36 23.7 13 31.7 1126 23.0
Q4 36 23.7 8 19.5 865 17.7
Q5 (highest) 23 15.1 9 22.0 948 19.4
Note: IBS - Irritable bowel syndrome; CD - Crohn’s disease; UC - Ulcerative colitis; – indicates that the results have been suppressed due to cell sizes less than 7.
aPercentages for this variable may not sum to 100 because of missing data
Table 3 Estimates of  for administrative and survey data
before and after the survey interview date
Condition 3 Years Before 1 Year After
Self-Reported IBS 0.22 (0.22, 0.23) 0.11 (0.11, 0.12)
Self-Reported CD or UC 0.65 (0.64, 0.66) 0.48 (0.46, 0.49)
Note: IBS - Irritable bowel syndrome; CD - Crohn’s disease; UC - Ulcerative
colitis; 95% confidence intervals are provided in parentheses.
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to three times higher among females than males [17],
which is consistent with the findings observed in this
study for both data sources. However, crude estimates
in this study were still lower than those reported in pre-
vious North American research [14,16,17]. This may be
due to a number of factors, including the lack of
specificity of the survey questions about bowel disorders
or the unfamiliarity of Manitoba physicians with diag-
nostic criteria for IBS. However, there is substantial
international variation in IBS prevalence estimates, with
some non-North American counties reporting values as
low as 3 and 5 per 100 [29]. The estimates obtained
from administrative data were higher for the oldest age
Table 4 Percentages of respondents with selected diagnoses and procedures before and after the survey interview
date
Diagnosis/Procedure Self-Reported IBS (n = 152) No Reported Bowel Disorder (n = 4,892)
3 Years Before 1 Year Before 1 Year After 3 Years Before 1 Year Before 1 Year After
%% % %% %
Hospitalization records
IBS 0.0 0.0 0.0 0.0 0.0 0.0
CD or UC – 0.0 0.0 0.2 0.0 0.0
All IBS-related diagnoses 0.0 0.0 0.0 0.0 0.0 0.0
Procedures
Sigmoidoscopy, colonoscopy, endoscopy 11.2* 3.8* 1.6
† 4.1 1.5 1.7
Small bowel series 0.0 0.0 0.0 0.0 0.0 0.0
Physician claims
IBS 9.4* 9.4* 10.7* 1.0 1.0 1.5
CD/UC 22.5* ––4.7 1.8 1.7
Gastric ulcer –– 0.0 –– 0.0
Duodenal ulcer –– 0.0 –– 0.0
Peptic ulcer 1.2
† ––0.9 0.3 0.3
Gastrojejunal ulcer 0.0 0.0 0.0 0.0 0.0 0.0
Gastritis and duodenitis 7.5* 3.5* 2.1* 3.4 1.2 1.1
Disorders of functions of the stomach 3.3* – 1.9* 2.2 0.8 0.8
Other disorders of stomach and duodenum –– 0.0 0.0 – 0.0
Appendicitis –– 0.0 0.0 0.1 0.2
Vascular insufficiency of intestine – 0.0 0.0 0.0 0.0 0.0
Intestinal obstruction 2.7* – 0.0 0.5 0.2 0.1
Diverticula of intestine 10.6* ––1.0 0.2 0.3
Necrosis of liver 0.0 0.0 0.0 0.0 – 0.0
Chronic liver disease –– – 0.2 0.1 0.1
Liver abscess & sequelae 0.0 0.0 0.0 0.0 0.0 0.0
Other disorders of liver –– 0.0 0.4 0.1 0.5
Cholelithiasis 0.0 0.0 0.0 0.0 0.0 0.0
Other disorders of gallbladder 0.0 0.0 0.0 0.4 0.1 0.2
Other disorders of biliary tract 0.0 0.0 0.0 0.2 – 0.0
Diseases of pancreas 0.0 0.0 0.0 0.0 0.1 0.0
Intestinal malabsorption 0.0 0.0 0.0 0.3 – 0.1
Symptoms: digestive system 8.4* 2.1 – 3.2 1.1 1.6
Symptoms: urinary system 4.3* 2.9* 4.2* 2.8 1.0 1.4
Symptoms: abdomen & pelvis 26.9* 12.9* 10.2* 12.9 4.9 5.6
Endometriosis –– – 0.4 – 0.3
Pain and other symptoms, female genital organs 5.6* ––3.1 1.5 1.9
Anxiety disorders 34.4* 19.7* 20.7* 19.3 9.4 8.3
Intestinal infections due to other organism –– – 0.6 0.3 0.3
Ill-defined intestinal infections –– 0.0 0.5 0.1 0.3
Note: IBS = irritable bowel syndrome; CD = Crohn’s disease; UC = ulcerative colitis; – indicates results have been suppressed due to cell sizes less than 7; *
indicates a c
2 test for IBS respondents and respondents with no bowel disorder that is significant at a = .05) and † indicates a c
2 test that is non-significant.
Unmarked numeric values for IBS respondents could not be tested due to zero/small cell sizes.
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consistent with the estimates obtained from survey data
nor with the estimates reported in previous research,
which show declining IBS prevalence with age [15]. This
may be a result of some loss of specificity for ascertain-
ing IBS cases in physician data because diagnoses in
Manitoba’s physician data are only recorded to the third
digit; very few IBS cases were identified from hospital
data, in which diagnoses are recorded with greater
specificity. This finding may also be a result of increased
reporting among older adults of a variety of symptoms
and/or an increased likelihood of inaccurate assignment
of an IBS diagnosis in older adults [30].
Well-defined chronic conditions are more likely to
result in good agreement between administrative and
survey data [8,31]. The Rome criteria have been devel-
oped to provide physicians with a systematic methodol-
ogy to classify individuals with functional
Figure 1 Sex-specific estimates of IBS prevalence from survey and administrative data.
Figure 2 Age-specific estimates of IBS prevalence from survey and administrative data.
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based on the results of medical chart review, Goff et al.
[20] reported that the criteria are infrequently used by
physicians to establish a diagnosis of IBS. Wilson et al.
[16] suggest that the use of the Rome criteria by physi-
cians may result in underestimation of IBS prevalence in
population-based research that uses medical records.
One limitation of this study is that it was not possible
to compare clinical data with the administrative data or
survey data. As well, the survey data do not contain
information about date of diagnosis, which would have
been useful for decisions about the number of years of
administrative data needed to ascertain disease cases.
Some diagnoses occurred infrequently in administrative
data and therefore it was not possible to test for differ-
ences between survey respondents with and without
IBS. Finally, as noted previously, only three-digit ICD-9
codes are available in physician claims data in Manitoba,
resulting in loss of specificity to ascertain IBS cases.
This situation is not unique in Canada; physician data
in Ontario, the largest province in Canada, is also lim-
ited to three-digit diagnosis codes [33]. However, there
is a lack of consistency across jurisdictions in the way
diagnoses are recorded in physician data. For example,
ICD-9 codes in Medicare physician data from the Uni-
ted States may be recorded using up to five digits [9].
Given the low agreement between survey and adminis-
trative data and evidence that this disease appears to be
under-reported in both data sources, it is important to
undertake further research that can improve IBS case
ascertainment in population-based data. Thompson et
al. [32] suggest that imprecision in the wording of sur-
vey questions contributes to inaccuracies in case ascer-
tainment. Wilson et al. [16] recommended that survey
questions based on the Rome criteria be supplemented
with additional questions to identify patients formerly
diagnosed with IBS but with symptoms currently under
control. Thus, future research could focus on comparing
agreement between administrative and survey data when
different question wording methods are adopted. For
administrative data, techniques that do not rely exclu-
sively on a single diagnosis code could be used to
improve ascertainment results for IBS. Machine-learning
and statistical classification models, including latent
class analysis and neural networks, which have been
applied to chronic conditions where there may be low
sensitivity associated with using a single diagnosis code
to ascertain disease cases [12,34,35], might be applied to
this problem.
Conclusions
Population-based chronic disease research can provide
important information about the effectiveness of disease
treatment and management initiatives and health
promotion and disease prevention strategies. The quality
of this research depends, in part, on the accuracy and
validity of chronic disease case ascertainment methods.
In both data sources, the use of a single methodology
for identifying disease cases may result in missed cases.
Finally, researchers who rely on either administrative
data or survey data to conduct population-based studies
about IBS should recognize that lack of comparability
between the two data sources will be an important con-
founder of their results.
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